KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,492,000 | +73.5% | 8,300 | 0.0% | 0.01% | +50.0% |
| Q2 2017 | $860,000 | +92.4% | 8,300 | +45.6% | 0.00% | +100.0% |
| Q1 2017 | $447,000 | +151.1% | 5,700 | +78.1% | 0.00% | +100.0% |
| Q3 2016 | $178,000 | +48.3% | 3,200 | +33.3% | 0.00% | 0.0% |
| Q2 2016 | $120,000 | – | 2,400 | – | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2015 | $55,000 | – | 900 | – | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2015 | $1,085,000 | +549.7% | 17,800 | +513.8% | 0.01% | +400.0% |
| Q1 2015 | $167,000 | -3.5% | 2,900 | -3.3% | 0.00% | 0.0% |
| Q4 2014 | $173,000 | +0.6% | 3,000 | -50.0% | 0.00% | – |
| Q3 2014 | $172,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |